Phenergan

Indications

For use as symptomatic treatment for allergic conditions of the upper respiratory tract and skin including allergic rhinitis, urticaria and anaphylactic reactions to drugs and foreign proteins; as an adjunct in preoperative sedation in surgery and obstetrics; and as an antiemetic. For short-term use: sedation and treatment of insomnia in adults; and as a paediatric sedative. Phenergan injection specifically has an additional indication as an adjunct in preoperative sedation in surgery and obstetrics and as a paediatric sedative.

Contraindications

Phenergan should not be used in patients in coma or suffering from CNS depression of any cause. Phenergan should not be given to patients with a known hypersensitivity to promethazine or to any of the excipients. Promethazine is contraindicated for use in children less than two years of age because of the potential for fatal respiratory depression. Phenergan should be avoided in patients taking monoamine oxidase inhibitors up to 14 days previously.

Price

56× 10mg tablets, £9.99; 56× 25mg tablets, £13.49; 5mg/5ml oral solution (100ml), £3.28; 25mg/ml solution for injection (10), £6.74

More on: Antihistamines